Login to Your Account

$415M Cash Deal

DeCode Genetics Buy Adds to Amgen's Genomics Arsenal

By Catherine Shaffer
Staff Writer

Tuesday, December 11, 2012
What began as discussions around a scientific collaboration a few months ago blossomed into a full acquisition deal between Amgen Inc., of Thousand Oaks, Calif., and DeCode Genetics, of Reykjavik, Iceland, according to Terry McGuire, of Polaris Venture Partners, which helped form DeCode in the 1990s, and in 2010 purchased it out of bankruptcy with Arch Ventures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription